“Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-Positive Patients”. 2023. Canadian Dermatology Today 4 (3): 5–10. https://canadiandermatologytoday.com/article/view/4-3-fournier.